Literature DB >> 24700887

An audit of hepatitis C service provision in a representative sample of prisons in England.

Clare Humphreys1, Cathie Railton2, Éamonn O'Moore3, Martin Lombard4, Autilia Newton2.   

Abstract

BACKGROUND: Prisons are an important setting to address prevention, testing and treatment of hepatitis C virus (HCV) and other blood-borne viruses. This audit examined current practice against national standards in a representative sample of prisons in England.
METHODS: The audit tool was developed based on best practice guidelines and piloted in one prison. In December 2012, the audit was conducted in a further 20 prisons, which were chosen to represent different types, sizes and geographical spread across England.
RESULTS: Testing for HCV was offered in the majority of prisons audited (20 of 21), but only two-thirds had a written policy on testing and treatment; less than a third had a steering group to oversee the process. The nature of services varied greatly. There were inconsistencies across data sources on testing.
CONCLUSIONS: This audit found that while there were many areas of good practice, the quality and content of hepatitis C service provision varied. It highlighted the need to provide appropriate guidance for prisons in delivering a high-quality service, ensuring that relevant training is available for different staff and that adequate psychosocial support is provided to patients.
© The Author 2014. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  communicable disease; prisons; public health

Mesh:

Year:  2014        PMID: 24700887     DOI: 10.1093/pubmed/fdu022

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  2 in total

1.  Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis.

Authors:  Natasha K Martin; Peter Vickerman; Iain F Brew; Joan Williamson; Alec Miners; William L Irving; Sushma Saksena; Sharon J Hutchinson; Sema Mandal; Eamonn O'Moore; Matthew Hickman
Journal:  Hepatology       Date:  2016-03-22       Impact factor: 17.425

2.  Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.

Authors:  Timothy Papaluca; Anne Craigie; Lucy McDonald; Amy Edwards; Michael MacIsaac; Jacinta A Holmes; Matthew Jarman; Tanya Lee; Hannah Huang; Andrew Chan; Mark Lai; Vijaya Sundararajan; Joseph S Doyle; Margaret Hellard; Mark Stoove; Jessica Howell; Paul Desmond; David Iser; Alexander J Thompson
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.